ARCHIVES

In Brief: Bristol To Drop Angiostatin; Protein Fails To Meet Criteria For Development, Firm Says

This article is from The Cancer Letter archive.

Vol. 25 No. 06 | February 12, 1999

Download PDF Visit The Full Archive

Related Articles

Contract Awards: Texas Group Receives $472,000 To Monitor Asbestos Workers

August 23, 1974

New Biologic Modalities Show Promise In Treatment Of Lymphomas, Research Finds

June 28, 2002

FCRF Recompetition Notice Of Intent

September 19, 1980

Foundation Offers Funding.

July 4, 2003

Michelle Le Beau named director of University of Chicago Cancer Research Center.

May 7, 2004

DCBD Board Okays Concept For New Cytogenetics RFA

August 3, 1984